ArticleNeurotrauma reports
CatWalk XT Enables Sensitive Detection of Locomotor Deficits after C2 Hemisection and Integrates Readily into Ongoing Experimental Workflows in Adult Female Rats.
Article in Neurotrauma reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Over half of all spinal cord injuries (SCIs) in the United States occur at the cervical level and often cause both life-threatening breathing dysfunction and profound locomotor deficits. Although the C2 hemisection (C2Hx) model is vital for study of breathing dysfunction after experimental SCI, post-C2Hx locomotor deficits have only been assessed by metrics such as the Martínez Scale and ladder tests, which require time-intensive scoring by human observers. However, the CatWalk XT Gait Analysis system (Noldus Information Technology) delivers automated, quantitative assessment of interlimb coordination, gait cycle, and paw function, providing robust locomotor data in a time-efficient and practical manner. CatWalk's efficiency may render it more feasible to incorporate locomotor analysis into studies that would not otherwise include such data, but it has not yet been applied to C2Hx. Thus, we conducted a proof-of-principle analysis using C2Hx-injured, adult female rats and uninjured naïve controls from two separate ongoing experiments. We hypothesized that C2Hx would produce primarily left-sided impairments measurable by CatWalk as predicted both by prior literature and the neuroanatomical specifics of the injury model. Indeed, CatWalk reliably identified pronounced deficits in left forepaw use and weight bearing, as well as impairments in stepping efficiency, interlimb coordination, speed, and overall gait stability across the 4-week period following injury. In summary, our findings demonstrate that CatWalk sensitively detects locomotor dysfunction after C2Hx and can be readily integrated into ongoing studies, thereby enhancing experimental efficiency and maximizing the scientific yield from existing animal cohorts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.